Related Experiment Video
Updated: Mar 6, 2026
08:31
Murine Model of Leukemia Relapse to Induction Chemotherapy for Acute Lymphoblastic Leukemia
Published on: October 17, 2025
788
Genetic Basis of Acute Lymphoblastic Leukemia
Ilaria Iacobucci1, Charles G Mullighan1
1All authors: St Jude Children's Research Hospital, Memphis, TN.
Summary
Genomic studies reveal distinct subtypes of acute lymphoblastic leukemia (ALL), impacting treatment and relapse. Genomic testing aids in precise diagnosis and therapy for this common childhood cancer.
Area of Science:
- Hematology
- Oncology
- Genetics
Background:
- Acute lymphoblastic leukemia (ALL) is the most common pediatric cancer, with high cure rates but significant long-term impact.
- Recent decades show major progress in understanding the genetic underpinnings of ALL development and treatment response.
Purpose of the Study:
- To review genomic studies in ALL.
- To discuss the clinical utility of genomic testing in managing ALL.
Main Methods:
- Review of recent genomic studies in acute lymphoblastic leukemia.
- Analysis of somatic DNA rearrangements and mutations in ALL subtypes.
- Evaluation of inherited genetic variants in leukemogenesis.
Main Results:
- ALL comprises multiple subtypes with unique genetic alterations affecting key cellular pathways.
- Genomic insights explain clonal evolution, relapse mechanisms, and the role of inherited factors.
- Clinical sequencing is improving ALL diagnosis, monitoring, and targeted therapy.
Conclusions:
- Genomic profiling is crucial for understanding ALL heterogeneity.
- Genomic testing offers significant potential to enhance clinical management and patient outcomes in ALL.
More Related Videos
Related Concept Videos
01:21Lineage Commitment
4.5K
Commitment is the process whereby stem cells:
4.5K
01:11Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase
56
Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...
56
02:41Lethal Alleles
18.7K
Agouti: A Lethal Allele
Lucien Cuénot discovered lethal alleles in 1905 while studying the inheritance of coat color in mice. The agouti gene is responsible for the color of the coat in mice. This gene codes for an agouti-signaling protein, which is responsible for melanin distribution in mammals. The wild-type allele gives rise to gray-brown coat color in mice, while the mutant allele gives rise to yellow coat color. In addition to coat color, the agouti gene is associated with the yellow...
Lucien Cuénot discovered lethal alleles in 1905 while studying the inheritance of coat color in mice. The agouti gene is responsible for the color of the coat in mice. This gene codes for an agouti-signaling protein, which is responsible for melanin distribution in mammals. The wild-type allele gives rise to gray-brown coat color in mice, while the mutant allele gives rise to yellow coat color. In addition to coat color, the agouti gene is associated with the yellow...
18.7K
02:21Cancers Originate from Somatic Mutations in a Single Cell
15.2K
Cancer arises from mutations in the critical genes that allow healthy cells to escape cell cycle regulation and acquire the ability to proliferate indefinitely. Though originating from a single mutation event in one of the originator cells, cancer progresses when the mutant cell lines continue to gain more and more mutations, and finally, become malignant. For example, chronic myelogenous leukemia (CML) develops initially as a non-lethal increase in white blood cells, which progressively...
15.2K
01:27Disorders of Leukocytes
2.2K
Leukocyte disorders can lead to either leukopenia, characterized by an abnormally low leukocyte count, or leukocytosis, marked by a very high leukocyte number.
Leukopenia may result from bone marrow disorders, autoimmune diseases, and infectious diseases. For example, conditions such as multiple myeloma and aplastic anemia can impair the bone marrow's ability to produce adequate leukocytes. Similarly, autoimmune diseases like lupus and viral infections such as HIV can prompt the immune...
Leukopenia may result from bone marrow disorders, autoimmune diseases, and infectious diseases. For example, conditions such as multiple myeloma and aplastic anemia can impair the bone marrow's ability to produce adequate leukocytes. Similarly, autoimmune diseases like lupus and viral infections such as HIV can prompt the immune...
2.2K